Innovating Works

VACCINE FORMULATION INSTITUTECHLTD

Desconocido
UltiMalVax: A Vaccine Targeting Eradication of Malaria VACCINE FORMULATION INSTITUTECHLTD participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has led to two anti-sporozoite vac...
2023-04-21 - 2027-04-30 | Financiado
ISIDORe: Integrated Services for Infectious Disease Outbreak Research VACCINE FORMULATION INSTITUTECHLTD participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado
TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE VACCINE FORMULATION INSTITUTECHLTD participó en un H2020: H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado
OptiMalVax: Optimizing a deployable high efficacy malaria vaccine VACCINE FORMULATION INSTITUTECHLTD participó en un H2020: H2020-SC1-2016-2017 A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vacc...
2016-12-09 - 2022-12-31 | Financiado
EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... VACCINE FORMULATION INSTITUTECHLTD participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.